Paper Details

  1. Home
  2. Paper Details

Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.

Author: BradburnB G, BrownR A, D'HollanderA, DiemunschP, FeissP, HahneW F, LeeserJ, NavéS, PanouillotP, PaxtonD, WhitmoreJ

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Dolasetron mesilate was both effective and safe in treating postoperative nausea and vomiting (PONV) in adult patients.
Paper Details　
Original Abstract of the Article :
PURPOSE: To compare the efficacy, safety, and tolerability of dolasetron mesilate with placebo for the treatment of postoperative nausea and vomiting (PONV). METHODS: In a randomized, multicentre, double-blind, placebo-controlled study 337 adult patients undergoing surgery with general anaesthesia ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF03013007

データ提供：米国国立医学図書館（NLM）

Dolasetron Mesilate: An Oasis in the Desert of Postoperative Nausea and Vomiting (PONV)

This research delves into the arid landscape of postoperative nausea and vomiting (PONV), a common and often uncomfortable experience for patients undergoing surgery. The study explores the efficacy and safety of dolasetron mesilate, a potential oasis of relief for those struggling with PONV. The study found that dolasetron mesilate was effective in reducing PONV symptoms and improving patient satisfaction, suggesting a potential solution for this challenging post-operative experience.

A Light in the Desert: Dolasetron Mesilate Shows Promise

This study suggests that dolasetron mesilate can provide relief from PONV, a common and often debilitating post-operative experience. The study's findings indicate that this medication can significantly reduce the frequency and severity of nausea and vomiting, potentially improving patient recovery and satisfaction.

Navigating the Desert of Post-Surgery: Dolasetron Mesilate Offers Relief

The research highlights the potential benefits of dolasetron mesilate in managing PONV, a common post-operative complication. It provides evidence to support its use as a safe and effective treatment option, potentially offering significant relief for patients. It's important to discuss any concerns or potential side effects with your healthcare provider to determine the best course of treatment for your individual situation.

Dr. Camel's Conclusion

This research provides a ray of hope in the arid landscape of postoperative nausea and vomiting. The discovery of an effective and safe medication like dolasetron mesilate is like finding a refreshing oasis in the desert. While further research is always necessary, this study offers valuable insights into potential solutions for managing this challenging post-operative experience. It reminds us that even in the most challenging situations, there is often a path to relief and healing.

Date :
  1. Date Completed 1997-05-15
  2. Date Revised 2019-11-01
Further Info :

Pubmed ID

9043731

DOI: Digital Object Identifier

10.1007/BF03013007

Related Literature

Article Analysis
・Effects of dolasetron injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.